Literature DB >> 19934824

Solar retinopathy: comparison of optical coherence tomography (OCT) and fluorescein angiography (FA).

Atul Jain1, Rajen U Desai, Resmi A Charalel, Polly Quiram, Lawrence Yannuzzi, David Sarraf.   

Abstract

PURPOSE: To compare optical coherence tomography with fluorescein angiography in 11 patients (21 eyes) with central foveal damage from solar retinopathy.
METHODS: Retrospective, observational case series of 11 patients with solar retinopathy. Dilated funduscopic examination was performed as well as photographic, fluorescein angiography, optical coherence tomography, and Humphrey visual field assessment.
RESULTS: Significant foveal pathology was identified in each of the 21 eyes (11 patients). Visual acuity in affected eyes ranged from 20/25 to 20/200. Optical coherence tomography demonstrated foveal atrophy associated with a characteristic defect at the level of the inner and outer segment junction of the photoreceptors in all 21 affected eyes, whereas fluorescein angiography identified classic window defects in 19 eyes (10 of 11 patients). There was a modest correlation between foveal thickness and visual acuity.
CONCLUSION: Fluorescein angiography did not detect lesions characteristic of solar retinopathy in all patients with a definitive history of sungazing and visual loss. Conversely, optical coherence tomography did detect significant foveal atrophy in all affected eyes and a characteristic defect at the photoreceptor-retinal pigment epithelium junction. Optical coherence tomography improves the diagnosis and assessment of the degree and nature of foveal damage in patients with solar retinopathy and may be an important tool in identifying foveal damage not detected by standard fluorescein angiography.

Entities:  

Mesh:

Year:  2009        PMID: 19934824     DOI: 10.1097/IAE.0b013e3181b0da88

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  20 in total

1.  Optical Coherence Tomography for Ophthalmology Imaging.

Authors:  Jia Qin; Lin An
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  NAD(+) maintenance attenuates light induced photoreceptor degeneration.

Authors:  Shi Bai; Christian T Sheline
Journal:  Exp Eye Res       Date:  2012-12-26       Impact factor: 3.467

3.  A reduced zinc diet or zinc transporter 3 knockout attenuate light induced zinc accumulation and retinal degeneration.

Authors:  Shi Bai; Carolyn R Sheline; Yongdong Zhou; Christian T Sheline
Journal:  Exp Eye Res       Date:  2012-12-26       Impact factor: 3.467

4.  Comparison of spectral-domain and time-domain optical coherence tomography in solar retinopathy.

Authors:  Han Joo Cho; Eun Seok Yoo; Chul Gu Kim; Jong Woo Kim
Journal:  Korean J Ophthalmol       Date:  2011-07-22

5.  Correlation of macular structure and function in a boy with primary foveomacular retinitis and sequence of changes over 5 years.

Authors:  Anurag Badhani; Tapas Ranjan Padhi; Gopal Krishna Panda; Sujoy Mukherjee; Taraprasad Das; Subhadra Jalali
Journal:  Doc Ophthalmol       Date:  2017-04-27       Impact factor: 2.379

Review 6.  [Impact of ultraviolet radiation on the retina].

Authors:  Marlene Saßmannshausen; Thomas Ach
Journal:  Ophthalmologe       Date:  2021-10-08       Impact factor: 1.059

7.  Solar retinopathy secondary to sungazing.

Authors:  Sarah Moran; Eamonn O'Donoghue
Journal:  BMJ Case Rep       Date:  2013-01-25

8.  [Eclipse retinopathy : A case series after the partial solar eclipse on 20 March 2015].

Authors:  I Bachmeier; H Helbig; R Greslechner
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

9.  Structural and genetic assessment of the ABCA4-associated optical gap phenotype.

Authors:  Kalev Nõupuu; Winston Lee; Jana Zernant; Stephen H Tsang; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-09       Impact factor: 4.799

10.  Acute Solar Retinopathy Imaged With Adaptive Optics, Optical Coherence Tomography Angiography, and En Face Optical Coherence Tomography.

Authors:  Chris Y Wu; Michael E Jansen; Jorge Andrade; Toco Y P Chui; Anna T Do; Richard B Rosen; Avnish Deobhakta
Journal:  JAMA Ophthalmol       Date:  2018-01-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.